Shared by @spennington.bsky.social on Bluesky ↗
abcnews.com2d ago
Shared by @bradenton.com on Bluesky ↗
bit.ly3d ago
Shared by @forbes.com on Bluesky ↗
forbes.com4d ago
temertymedicine.utoronto.ca9d ago
nautil.us2mo ago
Compass Pathways, a British biotech company, announced strong results from two late-stage trials showing that a synthetic form of psilocybin (the active compound in magic mushrooms) can rapidly relieve symptoms in patients with treatment-resistant depression. The FDA is now revie
economist.com·Hacker News: Front Page·3mo ago·1 min readThe FDA is announcing its intent to take action against non-FDA-approved GLP-1 drugs, specifically targeting GLP-1 active pharmaceutical ingredients used in compounded drugs that are being mass-marketed by companies. The agency plans to restrict these ingredients in compounded me
fda.gov·Hacker News: Front Page·3mo ago·2 min read
theguardian.com4mo ago
arstechnica.com6mo ago
semafor.com6mo ago
bbc.com7mo ago
science.org7mo ago
cnbc.com8mo ago
